A Missouri judge on Friday approved a $7.25bn (£5.5bn) settlement stemming from lawsuits alleging that Bayer's weedkiller Roundup causes cancer.
Judge Timothy Boyer said the settlement was "fair, reasonable, and adequate".
Bayer, the German bio-tech giant, had proposed paying the $7.25bn to definitively resolve a legal battle in the US.
The nationwide settlement will be paid to Roundup users who are already sick with non-Hodgkin lymphoma and those who fall ill in the future.
The company had already paid roughly $10bn to resolve litigation related to Roundup.
The settlements to participants range from $10,000 to $165,000, depending on how frequently they used the product, when they were diagnosed with the cancer and how severe their illness was.
Bayer will make annual payments into a fund for up to 21 years, providing as much as $7.25bn.
Some attorneys had objected to the settlement funds, arguing they were not enough, but the judge said he did not want to delay payouts to sick victims.
Bayer denies that its Roundup product causes cancer.
The settlement comes after the Supreme Court in June ruled in favour of Bayer, overturning a $1.25m settlement for a Missouri man who said Roundup and its ingredient glyphosate was to blame for his non-Hodgkin lymphoma.